Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder

L. Baer, M. A. Jenike, D. W. Black, C. Treece, R. Rosenfeld and J. Greist
Massachusetts General Hospital, Boston 02114.

We used the Structured Interview for DSM-III Personality Disorders to diagnose DSM-III personality disorders systematically in 55 patients with obsessive-compulsive disorder in the active-treatment cell of a controlled trial of clomipramine hydrochloride. Patients with a cluster A personality disorder had significantly higher obsessive-compulsive disorder severity scores at baseline, and the number of personality disorders was strongly related to baseline severity of obsessive-compulsive disorder symptoms. At the conclusion of the 12-week study, we found no significant difference in treatment outcome with clomipramine between those patients with at least one personality disorder and those with no personality disorders. However, the presence of schizotypal, borderline, and avoidant personality disorders, along with total number of personality disorders, did predict poorer treatment outcome. These variables were strongly related to having at least one cluster A personality disorder diagnosis, which was also a strong predictor of poorer outcome. Implications of these findings are discussed.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An autistic dimension: A proposed subtype of obsessive-compulsive disorder
Bejerot
Autism 2007;11:101-110.
ABSTRACT  

Obsessive-Compulsive Disorder
Greist and Jefferson
Focus 2007;5:283-298.
ABSTRACT | FULL TEXT  

Obsessive-Compulsive Disorder: An Update for the Clinician
Koran
Focus 2007;5:299-313.
FULL TEXT  

Bibliography for Obsessive-Compulsive Disorder
Focus 2007;5:328-329.
FULL TEXT  

Implementing Dialectical Behavior Therapy
Swenson et al.
Psychiatr. Serv. 2002;53:171-178.
ABSTRACT | FULL TEXT  

Personality disorders and normal personality dimensions in obsessive--compulsive disorder
SAMUELS et al.
Br. J. Psychiatry 2000;177:457-462.
ABSTRACT | FULL TEXT  

Use of Factor-Analyzed Symptom Dimensions to Predict Outcome With Serotonin Reuptake Inhibitors and Placebo in the Treatment of Obsessive-Compulsive Disorder
Mataix-Cols et al.
Am. J. Psychiatry 1999;156:1409-1416.
ABSTRACT | FULL TEXT  

Defense Mechanism Changes in Successfully Treated Patients With Obsessive-Compulsive Disorder
Albucher et al.
Am. J. Psychiatry 1998;155:558-559.
ABSTRACT | FULL TEXT